Dublin, Feb. 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical) has announced the addition of the "Biopharmaceutical Bioseparation Systems - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 52 companies including many key and niche players such as:
- 3M Company (US)
- 3M Purification, Inc. (US)
- Agilent Technologies, Inc. (US)
- Alfa Wassermann Separation Technologies, LLC (US)
- Flottweg Separation Technology (US)
- GEA Westfalia Separator Group GmbH (Germany)
- GE Healthcare (UK)
- KNAUER Wissenschaftliche Geräte GmbH (Germany)
- Konik Nanobiotech SL (Spain)
- Merck KGaA (Germany)
- NuSep Holdings Ltd. (Australia)
- Pall Corporation (US)
- ProMetic Life Sciences, Inc. (Canada)
- Sartorius Stedim Biotech (France)
- Spectrum Laboratories, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- Tosoh Bioscience, Inc. (Japan)
- YMC Europe GmbH (Germany)
Key Topics Covered:
1. Outlook
2. Industry Overview
3. Bioseparation Technologies - Key Trends
4. Product Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 60)
- The United States (32)
- Canada (1)
- Japan (5)
- Europe (18)
- - France (3)
- - Germany (9)
- - The United Kingdom (1)
- - Spain (1)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 



